QQ客服 官方微博 反馈留言

	Clinicopathological Significance of Decreased Expression of the Tumor Inhibitor Gene PDCD5 in Osteoclastoma
	Gao, Fei; Zhao, Miaoqing; Huang, Shanying; Zhang, Wei; Ma, Zhe
刊名	GENETIC TESTING AND MOLECULAR BIOMARKERS
	2019
卷号	23期号:11页码:807-814
关键词	reduced expression PDCD5 osteoclastoma clinicopathological significance
DOI	10.1089/gtmb.2019.0082
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4558348
专题	山东大学
作者单位	Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ,Chinese Natl Hlth Commiss, Jinan
推荐引用方式 GB/T 7714	Gao, Fei,Zhao, Miaoqing,Huang, Shanying,et al. Clinicopathological Significance of Decreased Expression of the Tumor Inhibitor Gene PDCD5 in Osteoclastoma[J]. GENETIC TESTING AND MOLECULAR BIOMARKERS,2019,23(11):807-814.
APA	Gao, Fei,Zhao, Miaoqing,Huang, Shanying,Zhang, Wei,&Ma, Zhe.(2019).Clinicopathological Significance of Decreased Expression of the Tumor Inhibitor Gene PDCD5 in Osteoclastoma.GENETIC TESTING AND MOLECULAR BIOMARKERS,23(11),807-814.
MLA	Gao, Fei,et al."Clinicopathological Significance of Decreased Expression of the Tumor Inhibitor Gene PDCD5 in Osteoclastoma".GENETIC TESTING AND MOLECULAR BIOMARKERS 23.11(2019):807-814.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。